Viewing Study NCT04550494


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2025-12-31 @ 11:46 AM
Study NCT ID: NCT04550494
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2020-09-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anatomic Stage III Breast Cancer AJCC v8 View
None Anatomic Stage IV Breast Cancer AJCC v8 View
None Castration-Resistant Prostate Carcinoma View
None Clinical Stage III Gastric Cancer AJCC v8 View
None Clinical Stage IV Gastric Cancer AJCC v8 View
None HER2-Positive Breast Carcinoma View
None Locally Advanced Breast Carcinoma View
None Locally Advanced Gastric Carcinoma View
None Locally Advanced Malignant Solid Neoplasm View
None Locally Advanced Ovarian Carcinoma View
None Locally Advanced Pancreatic Carcinoma View
None Locally Advanced Prostate Carcinoma View
None Metastatic Breast Carcinoma View
None Metastatic Gastric Carcinoma View
None Metastatic Malignant Solid Neoplasm View
None Metastatic Ovarian Carcinoma View
None Metastatic Pancreatic Carcinoma View
None Metastatic Prostate Carcinoma View
None Platinum-Sensitive Ovarian Carcinoma View
None Recurrent Breast Carcinoma View
None Recurrent Gastric Carcinoma View
None Recurrent Ovarian Carcinoma View
None Recurrent Pancreatic Carcinoma View
None Recurrent Prostate Carcinoma View
None Stage II Pancreatic Cancer AJCC v8 View
None Stage III Ovarian Cancer AJCC v8 View
None Stage III Pancreatic Cancer AJCC v8 View
None Stage III Prostate Cancer AJCC v8 View
None Stage IV Ovarian Cancer AJCC v8 View
None Stage IV Pancreatic Cancer AJCC v8 View
None Stage IV Prostate Cancer AJCC v8 View
Keywords: